Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Applied Physiology
Published in: European Journal of Applied Physiology 7/2014

01-07-2014 | Invited Review

Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids

Author: Peter L. McLennan

Published in: European Journal of Applied Physiology | Issue 7/2014

Login to get access

Abstract

Reduced cardiac mortality and morbidity have long been observed in association with omega-3 long chain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from fish consumption, without clear physiological explanation. This review seeks to identify mechanisms of action based on evidence: of physiological effects, active components and effective intakes. Fish oil pleiotropic effects reveal actions that are either intrinsic: effects on cardiac function dependent upon membrane incorporation; or extrinsic: indirect cardiac effects through vascular disease. Extrinsic actions require EPA + DHA doses >3 g/day. Intrinsic effects derive from usual dietary intakes, <1 g/day and include improved myocardial oxygen efficiency, heart rate, nutritional preconditioning against ischaemic injury, arrhythmias and heart failure. Myocardial Na+ and K+ currents are non-selectively modulated by omega-3 and omega-6 PUFA to stabilise cells in vitro, but not by fish oil-induced membrane change. In contrast, cellular Ca2+ overload involved in ischaemic injury, arrhythmia and spontaneous pacemaker activity are modulated by both dietary fish oil and in vitro omega-3 LC-PUFA. A potential linking role of bioactive epoxy and hydroxy PUFA derivatives requires investigation. Omega-3 DHA predominates over EPA in population intake, is preferentially incorporated into myocardium and is selectively active in heart rate and arrhythmia modulation, but EPA predominates in clinical trials. Myocardial selectivity for DHA and independent intrinsic and extrinsic physiological mechanisms underpinning diverse clinical endpoints can explain some contradictory outcomes of clinical trials. Intrinsic modulation of intracellular Ca2+ handling provides a unifying physiologically plausible basis for intrinsic fish oil actions and insight to nutritional optimisation of cardiac function.
Literature
Abbott SK, Else PL, Atkins TA, Hulbert AJ (2012) Fatty acid composition of membrane bilayers: importance of diet polyunsaturated fat balance. Biochim Biophys Acta-Biomembr 1818(5):1309–1317
Abdukeyum GG, Owen AJ, McLennan PL (2008) Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning. J Nutr 138(10):1902–1909PubMed
Abeywardena MY, Charnock JS (1983) Modulation of cardiac glycoside inhibition of (Na+ + K+)-ATPase by membrane lipids. Difference between species. Biochim Biophys Acta 729(1):75–84PubMed
Abeywardena MY, Charnock JS (1995) Dietary lipid modification of myocardial eicosanoids following ischemia and reperfusion in the rat. Lipids 30(12):1151–1156PubMed
Abeywardena MY, McLennan PL, Charnock JS (1987) Long-term saturated fat supplementation in the rat causes an increase in PGI2/TXB2 ratio of platelet and vessel wall compared to n-3 and n-6 dietary fatty acids. Atherosclerosis 66(3):181–189PubMed
Abeywardena MY, McLennan PL, Charnock JS (1991a) Differential effects of dietary fish oil on myocardial prostaglandin I2 and thromboxane A2 production. Am J Physiol 260(2 Pt 2):H379–H385PubMed
Abeywardena MY, McLennan PL, Charnock JS (1991b) Changes in myocardial eicosanoid production following long-term dietary lipid supplementation in rats. Am J Clin Nutr 53(4 Suppl):1039S–1041SPubMed
Abeywardena MY, McLennan PL, Charnock JS (1991c) Differences between in vivo and in vitro production of eicosanoids following long-term dietary fish oil supplementation in the rat. Prost Leuk Essent Fatty Acids 42(3):159–165
al Makdessi S, Brandle M, Ehrt M, Sweidan H, Jacob R (1995) Myocardial protection by ischemic preconditioning: the influence of the composition of myocardial phospholipids. Mol Cell Biochem 145(1):69–73PubMed
Albert CM, Hennekens CH, O’Donnell CJ, Ajani UA, Carey VJ, Willett WC, Ruskin JN, Manson JE (1998) Fish consumption and risk of sudden cardiac death. JAMA 279(1):23–28PubMed
Amano M, Kanda T, Ue H, Moritani T (2001) Exercise training and autonomic nervous system activity in obese individuals. Med Sci Sports Exerc 33(8):1287–1291PubMed
Anderson KE, Du XJ, Sinclair AJ, Woodcock EA, Dart AM (1996) Dietary fish oil prevents reperfusion Ins(1,4,5)P3 release in rat heart: possible antiarrhythmic mechanism. Am J Physiol 271(4 Pt 2):H1483–H1490PubMed
Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, Konkel A et al (2010) Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acids. J Biol Chem 285(43):32720–32733PubMedCentralPubMed
Bang HO, Dyerberg J (1972) Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Medica Scandinavica 192(1–2):85–94PubMed
Bang HO, Dyerberg J (1980) The bleeding tendency in Greenland Eskimos. Dan Med Bull 27(4):202–205PubMed
Baum SJ, Kris-Etherton PM, Willett WC, Lichtenstein AH, Rudel LL, Maki KC, Whelan J, Ramsden CE, Block RC (2012) Fatty acids in cardiovascular health and disease: a comprehensive update. J Clin Lipidol 6(3):216–234PubMed
Baur LA, O’Connor J, Pan DA, Wu BJ, O’Connor MJ, Storlien LH (2000) Relationships between the fatty acid composition of muscle and erythrocyte membrane phospholipid in young children and the effect of type of infant feeding. Lipids 35(1):77–82PubMed
Baxter GF, Ferdinandy P (2001) Delayed preconditioning of myocardium: current perspectives. Bas Res Cardiol 96(4):329–344
Berecki G, Den Ruijter HM, Verkerk AO, Schumacher CA, Baartscheer A, Bakker D, Boukens BJ et al (2007) Dietary fish oil reduces the incidence of triggered arrhythmias in pig ventricular myocytes. Heart Rhythm 4(11):1452–1460PubMed
Bilchick KC, Fetics B, Djoukeng R, Fisher SG, Fletcher RD, Singh SN, Nevo E, Berger RD (2002) Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol 90(1):24–28PubMed
Billman GE, Harris WS (2011) Effect of dietary omega-3 fatty acids on the heart rate and the heart rate variability responses to myocardial ischemia or submaximal exercise. Am J Physiol Heart Circ Physiol 300(6):H2288–H2299PubMedCentralPubMed
Billman GE, Hallaq H, Leaf A (1994) Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci 91(10):4427–4430PubMedCentralPubMed
Billman GE, Kang JX, Leaf A (1997) Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 32(11):1161–1168PubMed
Billman GE, Kang JX, Leaf A (1999) Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 99(18):2452–2457PubMed
Billman GE, Nishijima Y, Belevych AE, Terentyev D, Xu Y, Haizlip KM, Monasky MM et al (2010) Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies. Am J Physiol Heart Circ Physiol 298(4):H1219–H1228PubMedCentralPubMed
Billman GE, Carnes CA, Adamson PB, Vanoli E, Schwartz PJ (2012) Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation lack of protection and a proarrhythmic effect. Circ Arrhythmia Electrophysiol 5:553–560
Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV (1993) The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328(4):238–244PubMed
Brenna JT, Salem N, Sinclair AJ, Cunnane SC (2009) alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prost Leuk Essent Fatty Acids 80(2–3):85–91
Brown DA, Moore RL (2007) Perspectives in innate and acquired cardioprotection: cardioprotection acquired through exercise. J Appl Physiol 103(5):1894–1899PubMed
Bucher HC, Hengstler P, Schindler C, Meier G (2002) N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112(4):298–304PubMed
Burdge GC, Calder PC (2005) Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 45(5):581–597PubMed
Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2(8666):757–761PubMed
Cabo J, Alonso R, Mata P (2012) Omega-3 fatty acids and blood pressure. Brit J Nutr 107:S195–S200PubMed
Camm AJ, Malik M, Bigger JT, Breithardt G, Cerutti S, Cohen RJ, Coumel P et al (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17(3):354–381
Carney RM, Freedland KE, Stein PK, Steinmeyer BC, Harris WS, Rubin EH, Krone RJ, Rich MW (2010) Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease. Psychosom Med 72(8):748–754PubMedCentralPubMed
Casula M, Soranna D, Catapano AL, Corrao G (2013) Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: a meta-analysis of randomized, double blind, placebo controlled trials. Atheroscler Suppl 14(2):243–251PubMed
Charnock JS, Abeywardena MY, McLennan PL (1986) Comparative changes in the fatty-acid composition of rat cardiac phospholipids after long-term feeding of sunflower seed oil- or tuna fish oil-supplemented diets. Ann Nutr Metab 30(6):393–406PubMed
Charnock JS, Abeywardena MY, McLennan PL (1989) Tissue specific differences in the fatty acid composition of the marmoset monkey (Callithrix jacchus). Comp Biochem Physiol A Comp Physiol 92(3):299–304PubMed
Charnock JS, McLennan PL, Sundram K, Abeywardena MY (1991) Omega-3 PUFA’s reduce the vulnerability of the rat to ischaemic arrhythmia in the presence of a high intake of saturated animal fat. Nutr Res 11:1025–1034
Charnock JS, Abeywardena MY, Poletti VM, McLennan PL (1992) Differences in fatty acid composition of various tissues of the marmoset monkey (Callithrix jacchus) after different lipid supplemented diets. Comp Biochem Physiol A Comp Physiol 101(2):387–393
Christensen JH, Gustenhoff P, Korup E, Aaroe J, Toft E, Moller J, Rasmussen K, Dyerberg J, Schmidt EB (1996) Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. Brit Med J 312(7032):677–678PubMedCentralPubMed
Christensen JH, Korup E, Aaroe J, Toft E, Moller J, Rasmussen K, Dyerberg J, Schmidt EB (1997) Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 79(12):1670–1673PubMed
Christensen JH, Christensen MS, Dyerberg J, Schmidt EB (1999) Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr 70(3):331–337PubMed
Christensen JH, Skou HA, Fog L, Hansen V, Vesterlund T, Dyerberg J, Toft E, Schmidt EB (2001a) Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 103(5):651–657PubMed
Christensen JH, Skou HA, Madsen T, Torring I, Schmidt EB (2001b) Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Intern Med 249(6):545–552PubMed
Christensen JH, Svensson M, Strandhave C, Madsen T, Schmidt EB (2010) N-3 fatty acids and cardiac autonomic function in humans. Cell Mol Biol 56(1):131–139PubMed
Chung CS, Karamanoglu M, Kovacs SJ (2004) Duration of diastole and its phases as a function of heart rate during supine bicycle exercise. Am J Physiol Heart Circ Physiol 287(5):H2003–H2008PubMed
Clusin WT (2003) Calcium and cardiac arrhythmias: DADs, EADs, and alternans. Crit Revs Clin Lab Sci 40(3):337–375
Connor WE, DeFrancesco CA, Connor SL (1993) N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients. Ann N Y Acad Sci 683:16–34PubMed
Conquer JA, Roelfsema H, Zecevic J, Graham TE, Holub BJ (2002) Effect of exercise on FA profiles in n-3 FA-supplemented and -nonsupplemented premenopausal women. Lipids 37(10):947–951PubMed
Coronel R, Wilms-Schopman FJG, Den Ruijter HM, Belterman CN, Schumacher CA, Opthof T, Hovenier R et al (2007) Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc Res 73(2):386–394PubMed
Dallongeville J, Yarnell J, Ducimetiere P, Arveiler D, Ferrieres J, Montaye M, Luc G et al (2003) Fish consumption is associated with lower heart rates. Circulation 108(7):820–825PubMed
Danthi SJ, Enyeart JA, Enyeart JJ (2005) Modulation of native T-type calcium channels by omega-3 fatty acids. Biochem Biophys Res Commun 327(2):485–493PubMed
deJonge HW, Dekkers DHW, Bastiaanse EML, Bezstarosti K, van der Laarse A, Lamers JMJ (1996a) Eicosapentaenoic acid incorporation in membrane phospholipids modulates receptor-mediated phospholipase C and membrane fluidity in rat ventricular myocytes in culture. J Mol Cell Cardiol 28(5):1097–1108
deJonge HW, Dekkers DHW, Lamers JMJ (1996b) Polyunsaturated fatty acids and signalling via phospholipase C-beta and A(2) in myocardium. Mol Cell Biochem 157(1–2):199–210
Demaison L, Sergiel JP, Moreau D, Grynberg A (1994) Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on the mitochondrial oxidative metabolism before and after myocardial ischemia. Biochim Biophys Acta 1227(1–2):53–59PubMed
Demaison L, Moreau D, Martine L, Chaudron I, Grynberg A (1996) Myocardial ischemia and in vitro mitochondrial metabolic efficiency. Mol Cell Biochem 158(2):161–169PubMed
Dewailly E, Blanchet C, Lemieux S, Sauve L, Gingras S, Ayotte P, Holub BJ (2001a) n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74(4):464–473PubMed
Dewailly EE, Blanchet C, Gingras S, Lemieux S, Sauve L, Bergeron J, Holub BJ (2001b) Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am J Clin Nutr 74(5):603–611
Dewailly E, Blanchet C, Gingras S, Lemieux S, Holub BJ (2002) Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr 76(1):85–92PubMed
Di Marino L, Maffettone A, Cipriano P, Sacco M, Di Palma R, Amato B, Quarto G, Riccardi G, Rivellese AA (2000) Is the erythrocyte membrane fatty acid composition a valid index of skeletal muscle membrane fatty acid composition? Metab Clin Exp 49(9):1164–1166PubMed
Duda MK, O’Shea KM, Lei B, Barrows BR, Azimzadeh AM, McElfresh TE, Hoit BD, Kop WJ, Stanley WC (2007) Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 76(2):303–310PubMedCentralPubMed
Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2(8081):117–119PubMed
Fischer S, Weber PC (1983) Thromboxane-A3 (TXA3) is formed in human-platelets after dietary eicosapentaenoic acid (C20-5-omega-3). Biochem Biophys Res Commun 116(3):1091–1099PubMed
Fischer S, Weber PC (1984) Prostaglandin-I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 307(5947):165–168PubMed
Flock MR, Harris WS, Kris-Etherton PM (2013a) Long-chain omega-3 fatty acids: time to establish a dietary reference intake. Nutr Rev 71(10):692–707PubMed
Flock MR, Skulas-Ray AC, Harris WS, Etherton TD, Fleming JA, Kris-Etherton PM (2013b) Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J Am Heart Assoc 2(6):e000513PubMedCentralPubMed
Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG et al (2007) Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50(9):823–830PubMed
Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S (2011) Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. Brit Med J 342:7787
Garg ML, Leitch J, Blake RJ, Garg R (2006) Long-chain n-3 polyunsaturated fatty acid incorporation into human atrium following fish oil supplementation. Lipids 41(12):1127–1132PubMed
Geelen A, Brouwer IA, Schouten EG, Maan AC, Katan MB, Zock PL (2005) Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr 81(2):416–420PubMed
Gibson RA, Neumann MA, Lien EL, Boyd KA, Tu WC (2013) Docosahexaenoic acid synthesis from alpha-linolenic acid is inhibited by diets high in polyunsaturated fatty acids. Prost Leuk Essent Fatty Acids 88(1):139–146
Grant CC, van Rensburg DCJ (2013) The contribution of preintervention blood pressure, VO(2)max, BMI, autonomic function and gender to exercise-induced changes in heart rate variability. Br J Sports Med 47(9):575–578PubMed
Griffin BA (2008) How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol 19(1):57–62PubMed
Grimsgaard S, Bonaa KH, Hansen JB, Myhre ES (1998) Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 68(1):52–59PubMed
Grynberg A, Demaison L (1996) Fatty acid oxidation in the heart. J Cardiovasc Pharmacol 28(Suppl 1):S11–S17PubMed
Grynberg A, Oudot F, McLennan PL, Athias P (1997) Acides Gras Omega-3 et Prevention Cardiovasculaire. Cahiere de Nutition et Dietetiques 32(2):107–114
Gudbjarnason S (1989) Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern Med 225(Suppl 731):117–128
Guizy M, David M, Arias C, Zhang L, Cofan M, Ruiz-Gutierrez V, Ros E et al (2008) Modulation of the atrial specific Kv1.5 channel by the n-3 polyunsaturated fatty acid, alpha-linolenic acid. J Mol Cell Cardiol 44(2):323–335PubMed
Hallaq H, Sellmayer A, Smith TW, Leaf A (1990) Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes. Proc Natl Acad Sci 87(20):7834–7838PubMedCentralPubMed
Hallaq H, Smith TW, Leaf A (1992) Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci 89(5):1760–1764PubMedCentralPubMed
Harris WS (2006) The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep 8:453–459PubMed
Harris WS (2010) Omega-6 and omega-3 fatty acids: partners in prevention. Curr Opin Clin Nutr Metab Care 13:125–129PubMed
Harris WS, von Schacky C (2004) The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 39(1):212–220PubMed
Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM (2004) Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 110(12):1645–1649PubMed
Harris WS, Gonzales M, Laney N, Sastre A, Borkon AM (2006) Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. Am J Cardiol 98(10):1393–1395PubMed
Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC, Holden JM et al (2009a) Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 139(4):804S–819SPubMed
Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F (2009b) Omega-6 fatty acids and risk for cardiovascular disease a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119(6):902–907PubMed
Hartog JM, Lamers JM, Verdouw PD (1986) The effects of dietary mackerel oil on plasma and cell membrane lipids, on hemodynamics and cardiac arrhythmias during recurrent acute ischemia in the pig. Bas Res Cardiol 81(6):567–580
Hartog JM, Lamers JM, Achterberg PW, van Heuven-Nolsen D, Nijkamp FP, Verdouw PD (1987) The effects of dietary mackerel oil on the recovery of cardiac function after acute ischaemic events in the pig. Bas Res Cardiol 82(Suppl 1):223–234
Helge JW, Ayre KJ, Hulbert AJ, Kiens B, Storlien LH (1999) Regular exercise modulates muscle membrane phospholipid profile in rats. J Nutr 129:1636–1642PubMed
Helge JW, Wu BJ, Willer M, Daugaard JR, Storlien LH, Kiens B (2001) Training affects muscle phospholipid fatty acid composition in humans. J Appl Physiol 90(2):670–677PubMed
Hetzel BS, Charnock JS, Dwyer T, McLennan PL (1989) Fall in coronary heart disease mortality in USA and Australia due to sudden death: evidence for the role of polyunsaturated fat. J Clin Epidemiol 42(9):885–893PubMed
Hock CE, Beck LD, Bodine RC, Reibel DK (1990) Influence of dietary n-3 fatty acids on myocardial ischemia and reperfusion. Am J Physiol 259(5 Pt 2):H1518–H1526PubMed
Honen BN, Saint DA (2002) Polyunsaturated dietary fats change the properties of calcium sparks in adult rat atrial myocytes. J Nutr Biochem 13(6):322–329PubMed
Honen BN, Saint DA, Laver DR (2003) Suppression of calcium sparks in rat ventricular myocytes and direct inhibition of sheep cardiac RyR channels by EPA, DHA and oleic acid. J Memb Biol 196(2):95–103
Honore E, Barhanin J, Attali B, Lesage F, Lazdunski M (1994) External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty-acids. Proc Natl Acad Sci 91(5):1937–1941PubMedCentralPubMed
Hooper L, Griffiths E, Abrahams B, Alexander W, Atkins S, Atkinson G, Bamford R et al (2004) Dietetic guidelines: diet in secondary prevention of cardiovascular disease (first update, June 2003). J Hum Nutr Diet 17(4):337–349PubMed
Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV et al (2006) Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. Brit Med J 332(7544):752–760PubMedCentralPubMed
Hooper L, Harrison RA, Summerbell CD, Moore H, Worthington HV, Ness A, Capps N et al. (2009) Omega 3 fatty acids for prevention and treatment of cardiovascular disease (review). Cochrane database systematic reviews 2004, (issue 4)
Howe P, Meyer B, Record S, Baghurst K (2006) Dietary intake of long-chain (omega)-3 polyunsaturated fatty acids: contribution of meat sources. Nutrition 22(1):47–53PubMed
Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Mäkikallio TH, Juhani Airaksinen KE, Myerburg RJ (2003) Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 42(4):652–658PubMed
Investigators TCASTC (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321(6):406–412
Jahangiri A, Leifert WR, Patten GS, McMurchie EJ (2000) Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Mol Cell Biochem 206(1–2):33–41PubMed
Jahangiri A, Leifert WR, Kind KL, McMurchie EJ (2006) Dietary fish oil alters cardiomyocyte Ca2+ dynamics and antioxidant status. Free Radic Biol Med 40(9):1592–1602PubMed
Judé S, Bedut S, Roger S, Pinault M, Champeroux P, White E, Le Guennec JY (2003) Peroxidation of docosahexaenoic acid is responsible for its effects on I TO and I SS in rat ventricular myocytes. Br J Pharmacol 139(4):816–822PubMedCentralPubMed
Judé S, Martel E, Vincent F, Besson P, Couet C, Ogilvie GK, Pinault M et al (2007) Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-δ and protein kinase-C-ε translocation. Brit J Nutr 98(6):1143–1151PubMed
Kang JX (2012) Reduction of heart rate by omega-3 fatty acids and the potential underlying mechanisms. Front Physiol 3(416):1–6
Kang JX, Leaf A (1994) Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci 91(21):9886–9890PubMedCentralPubMed
Kang JX, Leaf A (1995) Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochem Biophys Res Commun 208(2):629–636PubMed
Kang JX, Leaf A (1996a) Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins. Proc Natl Acad Sci 93(8):3542–3546PubMedCentralPubMed
Kang JX, Leaf A (1996b) The cardiac antiarrhythmic effects of polyunsaturated fatty acid. Lipids 31(Suppl):S41–S44PubMed
Kang JX, Leaf A (1996c) Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes. Eur J Pharmacol 297(1–2):97–106PubMed
Kang JX, Xiao YF, Leaf A (1995) Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci 92(9):3997–4001PubMedCentralPubMed
Kang JX, Li Y, Leaf A (1997) Regulation of sodium channel gene expression by class I antiarrhythmic drugs and n-3 polyunsaturated fatty acids in cultured neonatal rat cardiac myocytes. Proc Natl Acad Sci 94(6):2724–2728PubMedCentralPubMed
Kannel WB, Kannel C, Paffenbarger RS, Cupples LA (1987) Heart-rate and cardiovascular mortality: the Framingham-study. Am Heart J 113(6):1489–1494PubMed
Keyes KT, Ye Y, Lin Y, Zhang C, Perez-Polo JR, Gjorstrup P, Birnbaum Y (2010) Resolvin E1 protects the rat heart against reperfusion injury. Am J Physiol Heart Circ Physiol 299(1):H153–H164PubMed
Khoueiry G, Rafeh NA, Sullivan E, Saiful F, Jaffery Z, Kenigsberg DN, Krishnan SC et al (2013) Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials. Heart Lung 42(4):251–256PubMed
Kleiger RE, Stein PK, Bigger JT (2005) Heart rate variability: measurement and clinical utility. Ann Noninvas Electrocardiol 10(1):88–101
Konkel A, Schunck WH (2011) Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. BBA-Proteins Proteomics 1814(1):210–222PubMed
Kris-Etherton PM, Harris WS, Appel LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106(21):2747–2757PubMed
Kromhout D, Bosschieter EB, Coulander CD (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart-disease. N Engl J Med 312(19):1205–1209PubMed
Kromhout D, Yasuda S, Geleijnse JM, Shimokawa H (2012) Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? Eur Heart J 33(4):436–443PubMedCentralPubMed
Lakatta EG, Maltsev VA, Vinogradova TM (2010) A coupled system of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart’s pacemaker. Circ Res 106(4):659–673PubMedCentralPubMed
Leaf A, Weber PC (1988) Cardiovascular effects of n-3 fatty acids. N Engl J Med 318(9):549–557PubMed
Leaf A, Xiao YF, Kang JX, Billman GE (2005) Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias. J Memb Biol 206(2):129–139
Lee JH, Ikeda I, Sugano M (1992) Effects of dietary n-6/n-3 polyunsaturated fatty acid balance on tissue lipid levels, fatty acid patterns, and eicosanoid production in rats. Nutrition 8(3):162–166PubMed
Leifert WR, McMurchie EJ, Saint DA (1999) Inhibition of cardiac sodium currents in adult rat myocytes by n-3 polyunsaturated fatty acids. J Physiol 520(Pt 3):671–679PubMedCentralPubMed
Leifert WR, Jahangiri A, McMurchie EJ (2000a) Membrane fluidity changes are associated with the antiarrhythmic effects of docosahexaenoic acid in adult rat cardiomyocytes. J Nutr Biochem 11(1):38–44PubMed
Leifert WR, Jahangiri A, Saint DA, McMurchie EJ (2000b) Effects of dietary n-3 fatty acids on contractility, Na+ and K+ currents in a rat cardiomyocyte model of arrhythmia. J Nutr Biochem 11(7–8):382–392PubMed
Leifert WR, Dorian CL, Jahangiri A, McMurchie EJ (2001) Dietary fish oil prevents asynchronous contractility and alters Ca2+ handling in adult rat cardiomyocytes. J Nutr Biochem 12(6):365–376PubMed
Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS (2003) n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the cardiovascular health study. Am J Clin Nutr 77(2):319–325PubMed
Lepran I, Nemecz G, Koltai M, Szekeres L (1981) Effect of a linoleic acid-rich diet on the acute phase of coronary occlusion in conscious rats: influence of indomethacin and aspirin. J Cardiovasc Pharmacol 3(4):847–853PubMed
Li Y, Kang JX, Leaf A (1997) Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. Prostaglandins 54(2):511–530PubMed
Lu T, Vanrollins M, Lee HC (2002) Stereospecific activation of cardiac ATP-sensitive K+ channels by epoxyeicosatrienoic acids: a structural determinant study. Mol Pharmacol 62(5):1076–1083PubMed
Lu T, Ye D, Wang XL, Seubert JM, Graves JP, Bradbury JA, Zeldin DC, Lee HC (2006) Cardiac and vascular K(ATP) channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J Physiol Lond 575(2):627–644PubMedCentralPubMed
Luo X, Cai H, Ni J, Bhindi R, Lowe HC, Chesterman CN, Khachigian LM (2009) c-Jun DNAzymes inhibit myocardial inflammation, ros generation, infarct size, and improve cardiac function after ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 29(11):1836–1842PubMed
Macleod JC, Macknight AD, Rodrigo GC (1998) The electrical and mechanical response of adult guinea pig and rat ventricular myocytes to omega-3 polyunsaturated fatty acids. Eur J Pharmacol 356(2–3):261–270PubMed
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG et al (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GISSI-Prevenzione. Circulation 105(16):1897–1903PubMed
Marini M, Lapalombella R, Margonato V, Ronchi R, Samaja M, Scapin C, Gorza L et al (2007) Mild exercise training, cardioprotection and stress genes profile. Eur J Appl Physiol 99(5):503–510PubMed
Matthan NR, Jordan H, Chung M, Lichtenstein AH, Lathrop DA, Lau J (2005) A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism 54(12):1557–1565PubMed
McLennan PL (1993) Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr 57(2):207–212PubMed
McLennan PL (2001) Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 36(Suppl):S111–S114PubMed
McLennan PL (2004) Omega-3 polyunsaturated fatty acid prevention of cardiac arrhythmia and sudden death: cellular or circulating? Curr Top Nutraceut Res 2(2):101–111
McLennan PL, Abeywardena MY (2005) Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death. J Memb Biol 206:85–102
McLennan PL, Dallimore JA (1995) Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. J Nutr 125(4):1003–1009PubMed
McLennan PL, Raederstorff D (1999) Diabetes puts myocardial n-3 fatty acid status at risk in the absence of supplementation in the rat. Lipids 34(Suppl):S91–S92PubMed
McLennan PL, Abeywardena MY, Charnock JS (1985) Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol 63(11):1411–1417PubMed
McLennan PL, Abeywardena MY, Charnock JS (1988) Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J 116(3):709–717PubMed
McLennan PL, Abeywardena MY, Charnock JS (1989a) The influence of age and dietary fat in an animal model of sudden cardiac death. Aust NZ J Med 19(1):1–5
McLennan PL, Charnock JS, Sundram K, Bridle TM, Abeywardena MY (1989b) Fish and the heart. Lancet ii:1451
McLennan PL, Abeywardena MY, Charnock JS (1990) Reversal of the arrhythmogenic effects of long-term saturated fatty acid intake by dietary n-3 and n-6 polyunsaturated fatty acids. Am J Clin Nutr 51(1):53–58PubMed
McLennan PL, Barnden LR, Bridle TM, Abeywardena MY, Charnock JS (1992a) Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc Res 26(9):871–877PubMed
McLennan PL, Bridle TM, Abeywardena MY, Charnock JS (1992b) Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J 123(6):1555–1561PubMed
McLennan PL, Bridle TM, Abeywardena MY, Charnock JS (1993) Comparative efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am J Clin Nutr 58(5):666–669PubMed
McLennan P, Howe P, Abeywardena M, Muggli R, Raederstorff D, Mano M, Rayner T, Head R (1996) The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol 300(1–2):83–89PubMed
McLennan PL, Owen AJ, Slee EL, Theiss ML (2007) Myocardial function, ischaemia and n-3 polyunsaturated fatty acids: a membrane basis. J Cardiovasc Med 8(suppl 1):S15–S18
McLennan PL, Abeywardena MY, Dallimore JA, Raederstorff D (2012) Dietary fish oil preserves cardiac function in the hypertrophied rat heart. Brit J Nutr 108:645–654PubMed
Metcalf RG, James MJ, Gibson RA, Edwards JRM, Stubberfield J, Stuklis R, Roberts-Thomson K, Young GD, Cleland LG (2007) Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr 85(5):1222–1228PubMed
Metcalf RG, Cleland LG, Gibson RA, Roberts-Thomson KC, Edwards JRM, Sanders P, Stuklis R, James MJ, Young GD (2010) Relation between blood and atrial fatty acids in patients undergoing cardiac bypass surgery. Am J Clin Nutr 91(3):528–534PubMed
Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PRC (2003) Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 38(4):391–398PubMed
Monfredi O, Maltsev VA, Lakatta EG (2013) Modern concepts concerning the origin of the heartbeat. Physiology 28(2):74–92PubMedCentralPubMed
Mori TA, Bao DQ, Burke V, Puddey IB, Beilin LJ (1999) Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34(2):253–260PubMed
Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ (2000) Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102(11):1264–1269PubMed
Morris MC, Sacks F, Rosner B (1993) Does fish oil lower blood pressure?: a meta-analysis of controlled trials. Circulation 88(2):523–533PubMed
Mozaffarian D (2005) Does alpha-linolenic acid intake reduce the risk of coronary heart disease?: a review of the evidence. Altern Ther Health Med 11(3):24–30PubMed
Mozaffarian D, Rimm EB (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296(15):1885–1899PubMed
Mozaffarian D, Wu JHY (2011) Omega-3 fatty acids and cardiovascular disease effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58(20):2047–2067PubMed
Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, Rimm EB (2005a) Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111(2):157–164PubMedCentralPubMed
Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS (2005b) Fish intake and risk of incident heart failure. J Am Coll Cardiol 45(12):2015–2021PubMed
Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB (2005c) The effect of fish oil on heart rate in humans: a meta-analysis of randomised controlled trials. Eur Heart J 26:677–678
Mozaffarian D, Prineas RJ, Stein PK, Siscovick DS (2006) Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. J Am Coll Cardiol 48(3):478–484PubMed
Mozaffarian D, Stein PK, Prineas RJ, Siscovick DS (2008) Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation 117(9):1130–1137PubMed
Murphy MG, Wright V, Scott J, Timmins A, Ackman RG (1999) Dietary menhaden, seal, and corn oils differentially affect lipid and ex vivo eicosanoid and thiobarbituric acid-reactive substances generation in the guinea pig. Lipids 34(2):115–124PubMed
Musa-Veloso K, Binns MA, Kocenas A, Chung C, Rice H, Oppedal-Olsen H, Lloyd H, Lemke S (2011) Impact of low v. moderate intakes of long-chain n-3 fatty acids on risk of coronary heart disease. Brit J Nutr 106(8):1129–1141PubMed
Myerburg RJ, Kessler KM, Bassett AL, Castellanos A (1989) A biological approach to sudden cardiac death: structure, function and cause. Am J Cardiol 63(20):1512–1516PubMed
Nair SSD, Leitch JW, Falconer J, Garg ML (1997) Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr 127(3):383–393PubMed
Nair SS, Leitch J, Falconer J, Garg ML (1999) Cardiac (n-3) non-esterified fatty acids are selectively increased in fish oil-fed pigs following myocardial ischemia. J Nutr 129(8):1518–1523PubMed
Nair SS, Leitch J, Garg ML (2000) Suppression of inositol phosphate release by cardiac myocytes isolated from fish oil-fed pigs. Mol Cell Biochem 215(1–2):57–64PubMed
Negretti N, Perez MR, Walker D, O’Neill SC (2000) Inhibition of sarcoplasmic reticulum function by polyunsaturated fatty acids in intact, isolated myocytes from rat ventricular muscle. J Physiol 523(Pt 2):367–375PubMedCentralPubMed
Nichols PD, Virttue P, Mooney BD, Elliott NG, Yearsley GK (1998) Seafood the good food: the oil (fat) content and composition of Australian commercial fishes, shellfishes and crustaceans. FRDC Project 95/122. CSIRO Division of Marine Sciences/Fisheries R&D Corporation, Australia, Hobart
Nordoy A, Marchioli R, Arnesen H, Videbaek J (2001) n-3 Polyunsaturated fatty acids and cardiovascular diseases. Lipids 36(Suppl):S127–S129PubMed
Nunan D, Sandercock GRH, Brodie DA (2010) A quantitative systematic review of normal values for short-term heart rate variability in healthy adults. PACE 33(11):1407–1417PubMed
O’Connor CI, Lawrence KM, Lawrence ACS, Janicki KM, Warren LK, Hayes S (2004) The effect of dietary fish oil supplementation on exercising horses. J Anim Sci 82(10):2978–2984PubMed
O’Keefe JH, Abuissa H, Sastre A, Steinhaus DM, Harris WS (2006) Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial Infarctions and depressed ejection fractions. Am J Cardiol 97(8):1127–1130PubMed
O’Neill SC, Perez MR, Hammond KE, Sheader EA, Negretti N (2002) Direct and indirect modulation of rat cardiac sarcoplasmic reticulum function by n-3 polyunsaturated fatty acids. J Physiol 538(1):179–184PubMedCentralPubMed
Oudot F, Grynberg A, Sergiel JP (1995) Eicosanoid synthesis in cardiomyocytes: influence of hypoxia, reoxygenation, and polyunsaturated fatty acids. Am J Physiol 268(1 Pt 2):H308–H315PubMed
Owen AJ, Peter-Przyborowska BA, Hoy AJ, McLennan PL (2004) Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition. Lipids 39(10):955–961PubMed
Patterson AC, Metherel AH, Hanning RM, Stark KD (2014) The percentage of DHA in erythrocytes can detect non-adherence to advice to increase EPA and DHA intakes. Brit J Nutr 111(02):270–278PubMed
Peng T-I, Jou M-J (2010) Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci 1201(1):183–188PubMed
Peoples GE, McLennan PL (2010) Dietary fish oil reduces skeletal muscle oxygen consumption, provides fatigue resistance and improves contractile recovery in the rat in vivo hindlimb. Brit J Nutr 104(12):1771–1779PubMed
Peoples GE, McLennan PL, Howe PRC, Groeller H (2008) Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 52(6):540–547PubMed
Pepe S, McLennan PL (1996) Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats. J Nutr 126(1):34–42PubMed
Pepe S, McLennan PL (2002) Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and post-ischemic recovery of contractile function. Circulation 105(19):2303–2308PubMed
Pepe S, McLennan PL (2007) (n-3) long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats. J Nutr 137(11):2377–2383PubMed
Pepe S, Bogdanov K, Hallaq H, Spurgeon H, Leaf A, Lakatta E (1994) Omega 3 polyunsaturated fatty acid modulates dihydropyridine effects on L-type Ca2+ channels, cytosolic Ca2+, and contraction in adult rat cardiac myocytes. Proc Natl Acad Sci 91(19):8832–8836PubMedCentralPubMed
Pepe S, Tsuchiya N, Lakatta EG, Hansford RG (1999) PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH. Am J Physiol 276(1 Pt 2):H149–H158PubMed
Piper HM (2000) The calcium paradox revisited: an artefact of great heuristic value. Cardiovasc Res 45(1):123–127PubMed
Powers SK, Quindry JC, Kavazis AN (2008) Exercise-induced cardioprotection against myocardial ischemia-reperfusion injury. Free Radic Biol Med 44(2):193–201PubMed
Richardson ES, Iaizzo PA, Xiao YF (2011) Electrophysiological mechanisms of the anti-arrhythmic effects of omega-3 fatty acids. J Cardiovasc Transl Res 4(1):42–52PubMed
Rinaldi B, Di Pierro P, Vitelli MR, D’Amico M, Berrino L, Rossi F, Filippelli A (2002) Effects of docosahexaenoic acid on calcium pathway in adult rat cardiomyocytes. Life Sci 71(9):993–1004PubMed
Risk and Prevention Study Collaborative Group (2013) n–3 Fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 368(19):1800–1808
Rocquelin G, Guenot L, Justrabo E, Grynberg A, David M (1985) Fatty acid composition of human heart phospholipids: data from 53 biopsy specimens. J Mol Cell Cardiol 17(8):769–773PubMed
Rodrigo GC, Dhanapala S, Macknight AD (1999) Effects of eicosapentaenoic acid on the contraction of intact, and spontaneous contraction of chemically permeabilized mammalian ventricular myocytes. J Mol Cell Cardiol 31(4):733–743PubMed
Rosen MR (1991) The sicilian gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Eur Heart J 12(10):1112–1131
Rosen MR, Janse MJ (2010) Concept of the vulnerable parameter: the Sicilian gambit revisited. J Cardiovasc Pharmacol 55(5):428–437PubMed
Schmidt EB, Skou HA, Christensen JH, Dyerberg J (2000) N-3 fatty acids from fish and coronary artery disease: implications for public health. Public Health Nutr 3(1):91–98PubMed
Schmidt EB, Arnesen H, Christensen JH, Rasmussen LH, Kristensen SD, De Caterina R (2005) Marine n-3 polyunsaturated fatty acids and coronary heart disease: part II. Clinical trials and recommendations. Thromb Res 115(4):257–262PubMed
Serhan CN (2004) A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol 122(4):305–321PubMed
Sexton PT, Sinclair AJ, O’Dea K, Sanigorski AJ, Walsh J (1995) The relationship between linoleic acid level in serum, adipose tissue and myocardium in humans. Asia Pacific J Clin Nutr 4:314–318
Siddiqui RA, Labarrere CA, Kovacs RJ (2000) Prevention of cardiac hypertrophy with omega 3-fatty acids: potential cell signaling targets. Curr Org Chem 4(11):1145–1156
Siddiqui RA, Harvey KA, Zaloga GP (2008) Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. J Nutr Biochem 19(7):417–437PubMed
Siebert BD, McLennan PL, Woodhouse JA, Charnock JS (1993) Cardiac arrhythmia in rats in response to dietary n-3 fatty acids from red meat, fish oil and canola oil. Nutr Res 13:1407–1418
Simopoulos AP (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60(9):502–507PubMed
Singh BN, Sarma JSM, Zhang Z-H, Takanaka C (1992) Controlling cardiac arrhythmias by lengthening repolarisation: rationale from experimental findings and clinical considerations. Ann N Y Acad Sci 644:187–209PubMed
Singleton CB, Valenzuela SM, Walker BD, Tie H, Wyse KR, Bursill JA, Qiu MR, Breit SN, Campbell TJ (1999) Blockade by N-3 polyunsaturated fatty acid of the Kv4.3 current stably expressed in Chinese hamster ovary cells. Br J Pharmacol 127(4):941–948PubMedCentralPubMed
Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V et al (1995) Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274(17):1363–1367PubMed
Skulas-Ray AC, Kris-Etherton PM, Harris WS, van den Heuvel JP, Wagner PR, West SG (2011) Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 93(2):243–252PubMedCentralPubMed
Slee EL, McLennan PL, Owen AJ, Theiss ML (2010) Low dietary fish oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats. J Lipid Res 51:1841–1848PubMedCentralPubMed
Sprecher H (2000) Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta Mol Cell Biol Lipids 1486(2–3):219–231
Stark KD (2008) The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues. Lipids 43(1):45–53PubMed
Stillwell W, Shaikh SR, Zerouga M, Siddiqui R, Wassall SR (2005) Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Devel 45(5):559–579
Streppel MT, Ocke MC, Boshuizen HC, Kok FJ, Kromhout D (2008) Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur Heart J 29(16):2024–2030PubMed
Tang WHW, Samara MA (2011) Polyunsaturated fatty acids in heart failure: should we give more and give earlier? J Am Coll Cardiol 57(7):880–883PubMedCentralPubMed
Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D et al (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372(9645):1223–1230PubMed
Valagussa F, Franzosi MG, Geraci E, Mininni N, Nicolosi GL, Santini M, Tavazzi L et al (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354(9177):447–455
Vandongen R, Mori TA, Burke V, Beilin LJ, Morris J, Ritchie J (1993) Effects on blood-pressure of omega-3 fats in subjects at increased risk of cardiovascular-disease. Hypertension 22(3):371–379PubMed
Vannice G, Rasmussen H (2014) Position of the academy of nutrition and dietetics: dietary fatty acids for healthy adults. J Acad Nutr Diet 114(1):136–153PubMed
Vedtofte MS, Jakobsen MU, Lauritzen L, Heitmann BL (2011) Dietary α-linolenic acid, linoleic acid, and n-3 long-chain PUFA and risk of ischemic heart disease. Am J Clin Nutr 94(4):1097–1103PubMed
Verkerk AO, den Ruijter HM, Bourier J, Boukens BJ, Brouwer IA, Wilders R, Coronet R (2009a) Dietary fish oil reduces pacemaker current and heart rate in rabbit. Heart Rhythm 6(10):1485–1492PubMed
Verkerk AO, den Ruijter HM, de Jonge N, Coronel R (2009b) Fish oil curtails the human action potential dome in a heterogeneous manner: implication for arrhythmogenesis. Int J Cardiol 132(1):138–140PubMed
Villa B, Calabresi L, Chiesa G, Rise P, Galli C, Sirtori CR (2002) Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmacol Res 45(6):475–478PubMed
Vinogradova TM, Lakatta EG (2009) Regulation of basal and reserve cardiac pacemaker function by interactions of cAMP-mediated PKA-dependent Ca2+ cycling with surface membrane channels. J Mol Cell Cardiol 47(4):456–474PubMedCentralPubMed
Wachira JK, Larson MK, Harris WS (2014) n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights. Brit J Nutr FirstView available on CJO2014. doi:10.​1017/​S000711451300425​X.​:​1-11
Westphal C, Konkel A, Schunck WH (2011) CYP-eicosanoids-A new link between omega-3 fatty acids and cardiac disease? Prostaglandins Other Lipid Mediat 96(1–4):99–108PubMed
Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B (2012) Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation Omega-3 fatty acids and their resolvin/protectin mediators. Prostaglandins Other Lipid Mediat 97(3–4):73–82PubMed
Wilk JB, Tsai MY, Hanson NQ, Gaziano JM, Djousse L (2012) Plasma and dietary omega-3 fatty acids, fish intake, and heart failure risk in the physicians’ health study. Am J Clin Nutr 96(4):882–888PubMedCentralPubMed
Williams EMV (1991) Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial. J Clin Pharmacol 31(2):123–135
Woodcock EA, Anderson KE, Du XJ, Dart AM (1995) Effects of dietary-fat supplementation on inositol phosphate release and metabolism in rat left atria. J Mol Cell Cardiol 27(3):867–871PubMed
Woodcock EA, Lambert KA, Du XJ (1996) Ins(1,4,5)P3 during myocardial ischemia and its relationship to the development of arrhythmias. J Mol Cell Cardiol 28:2129–2138PubMed
Xiao YF, Kang JX, Morgan JP, Leaf A (1995) Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci 92(24):11000–11004PubMedCentralPubMed
Xiao YF, Gomez AM, Morgan JP, Lederer WJ, Leaf A (1997) Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci 94(8):4182–4187PubMedCentralPubMed
Xiao YF, Wright SN, Wang GK, Morgan JP, Leaf A (1998) Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel. Proc Natl Acad Sci 95(5):2680–2685PubMedCentralPubMed
Xiao YF, Ke QG, Wang SY, Yang YK, Chen Y, Wang GK, Morgan JP, Cox B, Leaf A (2004) Electrophysiologic properties of lidocaine, cocaine, and n-3 fatty-acids block of cardiac Na+ channels. Eur J Pharmacol 485(1–3):31–41PubMed
Xiao YF, Sigg DC, Leaf A (2005) The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. J Memb Biol 206(2):141–154
Xiao YF, Ma L, Wang SY, Josephson ME, Wang GK, Morgan JP, Leaf A (2006) Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids. Am J Physiol Cell Physiol 290(2):C362–C370PubMed
Xin W, Wei W, Li XY (2012) Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials. Heart 98(22):1620–1625PubMed
Xin W, Wei W, Li X-Y (2013) Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials. Am J Clin Nutr 97(5):926–935PubMed
Yang B, Saldeen TG, Nichols WW, Mehta JL (1993) Dietary fish oil supplementation attenuates myocardial dysfunction and injury caused by global ischemia and reperfusion in isolated rat hearts. J Nutr 123(12):2067–2074PubMed
Yaniv Y, Spurgeon HA, Lyashkov AE, Yang DM, Ziman BD, Maltsev VA, Lakatta EG (2012) Crosstalk between mitochondrial and sarcoplasmic reticulum Ca2+ cycling modulates cardiac pacemaker cell automaticity. PLoS One 7(5)
Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S et al (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis. Lancet 369(9567):1090–1098PubMed
Zaloga GP, Ruzmetov N, Harvey KA, Terry C, Patel N, Stillwell W, Siddiqui R (2006) (n-3) Long-chain polyunsaturated fatty acids prolong survival following myocardial infarction in rats. J Nutr 136(7):1874–1878PubMed
Zaugg CE, Wu ST, Lee RJ, Parmley WW, Buser PT, Wikman-Coffelt J (1996) Importance of calcium for the vulnerability to ventricular fibrillation detected by premature ventricular stimulation: single pulse versus sequential pulse methods. J Mol Cell Cardiol 28(5):1059–1072PubMed
Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH (2009) Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med 41(4):301–310PubMed
Metadata
Title
Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids
Author
Peter L. McLennan
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Applied Physiology / Issue 7/2014
Print ISSN: 1439-6319
Electronic ISSN: 1439-6327
DOI
https://doi.org/10.1007/s00421-014-2876-z

Other articles of this Issue 7/2014

European Journal of Applied Physiology 7/2014 Go to the issue

Original Article

Thermal sensitivity to warmth during rest and exercise: a sex comparison

Original Article

Changes in contractile and elastic properties of the triceps surae muscle induced by neuromuscular electrical stimulation training

Original Article

Higher cardiorespiratory fitness attenuates the risk of atherosclerosis associated with ADRB3 Trp64Arg polymorphism

Original Article

High-intensity intermittent cycling increases purine loss compared with workload-matched continuous moderate intensity cycling

Original Article

Pacing strategies during repeated maximal voluntary contractions

Original Article

Acute effects of continuous and interval low-intensity exercise on arterial stiffness in healthy young men